Lean Six Sigma Approach Ups Quality of Hip Replacement Sx

This article originally appeared here.
Share this content:
Lean Six Sigma Approach Ups Quality of Hip Replacement Sx
Lean Six Sigma Approach Ups Quality of Hip Replacement Sx

FRIDAY, May 22, 2015 (HealthDay News) -- The Lean Six Sigma approach can be implemented to improve quality of care and reduce costs in prosthetic hip replacement surgery, according to a study published online May 11 in the Journal of Evaluation in Clinical Practice.

Giovanni Improta, Ph.D., from the University of Naples Federico II in Italy, and colleagues examined whether Lean Six Sigma represents an appropriate methodology for the development of a clinical pathway to improve quality and reduce costs associated with prosthetic hip surgery. Problem solving in Lean Six Sigma follows the Define, Measure, Analyze, Improve, Control pathway, and is characterized by five operational phases in order to reach fixed goals.

The researchers identified several variables that influence the inappropriate prolongation of length of stay for inpatient treatment. Corrective actions were undertaken to improve the effectiveness and efficiency of the care processes. There was a 44 percent reduction in the average length of stay, from 18.9 to 10.6 days after implementation of these improvement actions.

"This article shows there is no trade-off between quality and costs: Lean Six Sigma improves quality and, at the same time, reduces costs," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »